Teva Pharmaceutical Industries Limited · TASE:TEVA
Kalif Eliyahu Sharon sold 153,251 Teva Pharmaceutical Industries Limited shares (Form 4)
Traded May 14, 2026 · Filed May 18, 2026
On May 14, 2026, Kalif Eliyahu Sharon (EVP, Chief Financial Officer) sold 153,251 Teva Pharmaceutical Industries Limited shares at US$35.61 for US$5.46M under a trading plan, leaving 172,184 shares. Filed May 18, 2026 (Form 4).
- Sold
- 153,251 shares
- Price
- US$35.61
- Value
- US$5.46M
- Holding after
- 172,184 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP, Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Ordinary Shares | Sale | 153,251 | US$35.61 | 172,184 | Direct |
Source
Related
- Teva Pharmaceutical Industries Limited
- Kalif Eliyahu Sharon
- Teva Pharmaceutical Industries Limited shareholders
- Form 4 · Kalif Eliyahu Sharon · Jun 16, 2026
- Form 4 · Savage Brian · Sep 22, 2026
- Form 4 · Mignone Roberto · Sep 22, 2026
- Form 4 · Weiss Amir · Aug 25, 2026
- Form 4 · Satchi-Fainaro Ronit · Aug 25, 2026
- Form 4 · Lippman Evan · Aug 19, 2026